European Archives - Page 237 of 1060 - European Medical Journal

Early Blood Glucose Control Can Minimise Diabetes-Related Complications

Intensive control of blood glucose early on can minimise the lifetime risk of diabetes-related complications, if managed early enough.

Point-of-Care Testing Versus Traditional Methods for Infliximab Monitoring

Infliximab (IFX) is increasingly the prescribed therapy for chronic inflammatory bowel disease in paediatric patients. Successful treatment with IFX is dependent on numerous factors…

Picture of a pink illustrated brain on a mint green background

Elon Musk’s Neuralink seeks patients for clinical trial

Neuralink, Elon Musk’s brain chip company, is preparing for the first clinical trial of its implant technology.

Disparities in Cancer Stage Outcomes Across Catchment Areas

A study reveals significant disparities in cancer staging outcomes for patients treated at the Sidney Kimmel Comprehensive Cancer Center.

Positive Fertility Outcomes for Young Breast Cancer Survivors

New research provides hopeful news for young women treated for breast cancer who wish to have children.

Hypnosis: A Magical Tool in Clinical Scenarios – Part 2

In this second instalment, Sarah Partridge discusses success stories of hypnosis in a medical setting, and the potential benefits it provides to patient care.

Interview: Rizwan Rajak

Ever since medical school, I was always interested in musculoskeletal medicine and found this one of the most compelling subjects…

JHEP Reports: New Opinion Paper Published on the Diagnosis and Treatment of PFIC

This video summarises the key recommendations of a new opinion paper by McKiernan JP et al on the diagnosis and treatment …

Many Childhood Cancer Survivors Do Not Undergo Recommended Tests For Late Effects

A new retrospective cohort study has revealed concerning findings about the adherence to surveillance guidelines among adult survivors of childhood cancer in Ontario, Canada.

Risk of Sudden Cardiac Death in Patients Undergoing Cancer Treatment

A recent study conducted at the University of Rochester Medical Centre, New York, USA, has shed light on the risk of sudden cardiac death (SCD) among cancer patients undergoing active treatment.